A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Women's Cancers Bookmark and Share

Women's Cancers

The power of collaboration and a dedication to compassion
 
The Women’s Cancers Program at City of Hope brings together medical doctors and laboratory researchers from across City of Hope who are committed to increasing our understanding of the risks for developing breast and gynecologic (uterus, ovary, and cervix) cancers, developing novel strategies for treatment and prevention, and improving the lives of patients. These unique collaborations result in the rapid translation of scientific discoveries into more effective treatments for breast and gynecologic cancers.
 
 
Changing our patients' lives today

Our research serves as the foundation for developing new treatments for women diagnosed with cancer. Educating women about risk reduction, disease management, and post-treatment care is a major element of the program. We offer a wide range of clinical services, including screening/imaging/diagnostic approaches; genetic counseling and risk assessment; multidisciplinary therapeutic interventions including surgery, medical oncology, radiation oncology and reconstructive surgery procedures; rehabilitation and supportive care; long-term follow-up care; and prevention strategies.
 
We are the only women’s cancers program in the country to offer a biopsychosocial approach to care. We focus not just on the disease but on the biological, psychological and social factors that play a significant role in the lives of women battling cancer.
 
The Women's Cancers Program at City of Hope is among only a few in the nation to offer minimally invasive robotic surgery using the da Vinci S HD Surgical System. This robotic surgical approach offers greater accuracy, smaller incisions, less postoperative pain and faster healing.
 
We are among a few women’s cancers programs in the country to routinely use intraperitoneal (IP) chemotherapy to treat certain types of gynecologic cancer, which can greatly improve the outcomes for women with advanced disease.

Our patients are given the opportunity to participate in clinical trials. We are constantly evaluating new drugs and developing better treatments for breast and gynecologic cancers, designed to improve the likelihood of a cure. Many of these new treatment approaches are available only at City of Hope.

The Women’s Cancers Program at City of Hope, one of the largest in Southern California, continues to grow to meet the need for highly specialized and leading cancer care. We are at the forefront of breast and gynecologic cancer treatment and research, and we take a comprehensive and aggressive approach to provide the most advanced treatments available.

Care continues after treatment

Our doctors and researchers are working to develop resources to help improve the lives of women after treatment, and all patients are able to participate in ongoing long-term research that focuses on life after cancer.
 

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts - and those of our supporters today -- have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Director
Phone: 213-241-7250
Email: jmorgan@coh.org

 
 

Women's Cancers

Women's Cancers

The power of collaboration and a dedication to compassion
 
The Women’s Cancers Program at City of Hope brings together medical doctors and laboratory researchers from across City of Hope who are committed to increasing our understanding of the risks for developing breast and gynecologic (uterus, ovary, and cervix) cancers, developing novel strategies for treatment and prevention, and improving the lives of patients. These unique collaborations result in the rapid translation of scientific discoveries into more effective treatments for breast and gynecologic cancers.
 
 
Changing our patients' lives today

Our research serves as the foundation for developing new treatments for women diagnosed with cancer. Educating women about risk reduction, disease management, and post-treatment care is a major element of the program. We offer a wide range of clinical services, including screening/imaging/diagnostic approaches; genetic counseling and risk assessment; multidisciplinary therapeutic interventions including surgery, medical oncology, radiation oncology and reconstructive surgery procedures; rehabilitation and supportive care; long-term follow-up care; and prevention strategies.
 
We are the only women’s cancers program in the country to offer a biopsychosocial approach to care. We focus not just on the disease but on the biological, psychological and social factors that play a significant role in the lives of women battling cancer.
 
The Women's Cancers Program at City of Hope is among only a few in the nation to offer minimally invasive robotic surgery using the da Vinci S HD Surgical System. This robotic surgical approach offers greater accuracy, smaller incisions, less postoperative pain and faster healing.
 
We are among a few women’s cancers programs in the country to routinely use intraperitoneal (IP) chemotherapy to treat certain types of gynecologic cancer, which can greatly improve the outcomes for women with advanced disease.

Our patients are given the opportunity to participate in clinical trials. We are constantly evaluating new drugs and developing better treatments for breast and gynecologic cancers, designed to improve the likelihood of a cure. Many of these new treatment approaches are available only at City of Hope.

The Women’s Cancers Program at City of Hope, one of the largest in Southern California, continues to grow to meet the need for highly specialized and leading cancer care. We are at the forefront of breast and gynecologic cancer treatment and research, and we take a comprehensive and aggressive approach to provide the most advanced treatments available.

Care continues after treatment

Our doctors and researchers are working to develop resources to help improve the lives of women after treatment, and all patients are able to participate in ongoing long-term research that focuses on life after cancer.
 

Support This Program

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts - and those of our supporters today -- have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Director
Phone: 213-241-7250
Email: jmorgan@coh.org

 
 
City of Hope Locations

The Positive Image Center is where licensed cosmetologists support and assist patients with building and maintaining self-confidence in their appearance. Patients can access wig fittings and stylings and discuss cosmetic techniques.
 
Cooper Finkel Women’s Health Center
Many gynecological cancer and breast cancer  services at City of Hope are provided at the Rita Cooper Finkel and J. William Finkel Women's Health Center. Here, women receive the highest quality care, whether seeking prevention and screening services or coping with a cancer diagnosis.
Physicians in the United States and throughout the world are welcome to refer patients to City of Hope.

There are a number of options you can choose from to refer a patient:

  • Call 800-826-HOPE (4673) to speak with a patient referral specialist.
  • Fax the patient face sheet to 626-301-8432
  • Complete an online callback request form
 
Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...